ArticleBMC pharmacology & toxicology2023
Long-term survival in venous thromboembolic disease: rivaroxaban vs. warfarin - propensity score matching study.
Estefan Ramos-Isaza et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it